What is Elevation Spine?
Headquartered in Monterey, California, Elevation Spine stands as a leading innovator in the field of integrated-fixation spinal technologies. The company's core value proposition centers on its proprietary Saber Technology, a differentiated platform designed to modernize traditional spinal systems. By prioritizing improved patient outcomes through advanced engineering, Elevation Spine has carved out a distinct niche in the orthopedic market. The firm's focus on high-precision medical devices addresses critical gaps in current surgical interventions, positioning it as a high-growth entity within the broader healthcare technology landscape. As the company scales, its commitment to clinical efficacy and technological differentiation remains the cornerstone of its market strategy.
How much funding has Elevation Spine raised?
Elevation Spine has raised a total of $11M across 1 funding round:
Series B
$11M
Series B (2022): $11M with participation from Mutual Capital Partners and Technology Venture Partners
Key Investors in Elevation Spine
Mutual Capital Partners
Mutual Capital Partners is a Cleveland-based venture capital fund that focuses on investing in early-stage software and medical device companies in the Midwest, providing both financial support and strategic guidance.
Technology Venture Partners
Technology Venture Partners is a California-based venture capital and private equity firm that specializes in supporting high-growth technology and healthcare enterprises.
What's next for Elevation Spine?
With the recent infusion of capital, Elevation Spine is poised to scale its operational footprint and deepen its market penetration. The strategic focus will likely shift toward expanding the clinical adoption of the Saber Technology platform, potentially through increased investment in physician training programs and clinical research initiatives. Furthermore, the company is expected to leverage this financial backing to strengthen its supply chain and manufacturing capabilities, ensuring it can meet the rising demand for its integrated-fixation solutions. As the firm matures, it will likely explore further R&D efforts to broaden its product portfolio, solidifying its status as a key player in the spinal surgery innovation ecosystem. The current funding environment suggests a clear path toward long-term sustainability and potential leadership in the orthopedic device industry.
See full Elevation Spine company page
